News
Empowering Women in Legacy Sectors: Celebrating Innovators in Manufacturing and Supply Chain
Susan features Charu Thomas, Haley Keith, and Lisa Mullen.
Cortado Ventures Doubleshot Newsletter: March 2024
Midcon VC Summit, Nuview, Ardley, and more.
Why We Invested: Cadenza Bio
Cortado Ventures invests in Cadenza Bio
Forbes: Cortado Ventures Recognized for Diversity Advocacy
We are proud to be recognized by Forbes.
Nuview: Nuview Acquires Astraea
Nuview acquires Astrea
Ardley: Launches Underwriting Engine
CEO and Founder of Ardley sits down for an exclusive interview
Cody Merrill: A Cortado Conversation with CorriXR Therapeutics CEO Deborah Moorad
CorriXR Therapeutics is the first spinout of ChristianaCare, a large Delaware-based healthcare system
Cortado Ventures Doubleshot Newsletter: February 2024
2023 Year in Review, Lumata Health, CorriXR and more.
CorriXR: OETA Feature
Our Principal, Susan Moring, joined CorriXR CEO, Deborah Moorad
Axios: Lumata Health hauls in $5.5M for virtual eye care
We are excited to share an exclusive feature published by Axios
Fortune: What do VCs really want from the Fed
This article discusses the impact of the Federal Reserve’s decision
Why We Invested: Lumata Health
Check out our latest “Why We Invested” blog
Nathaniel Harding: Year in Review and 2024 Outlook
Let’s look back at 2023 for VC and our firm to set the stage for an exciting 2024
Cortado Ventures Doubleshot Newsletter: January 2024
MidCon Markup, CorriXR, Nathaniel Harding, and more
Cortado Ventures Invests in CorriXR
Cortado Ventures Invests in CorriXR
CORTADO VENTURES